← Back to headlines
Iovance Stock Rises on Australian Approval of Melanoma Therapy Amtagvi
Iovance Biotherapeutics shares increased after Australia granted approval for its melanoma therapy, Amtagvi, marking a significant regulatory milestone for the company.
4 Jun, 16:27 — 4 Jun, 16:27
Sources
Showing 1 of 1 sources
